News Focus
News Focus
icon url

DoubleJ23

12/11/17 12:07 PM

#207360 RE: KMBJN #207357

Thanks for this response. It is a nice contrast to have someone post an accurate reading of the data presented and have an understanding of how trial protocols actually work.
icon url

farrell90

12/11/17 12:15 PM

#207363 RE: KMBJN #207357

Nice insight into trial results. The relatively good results should lead to some enthusiasm for the FDA stage 3 trial and lead to a more robust trial.

The secondary outcomes from the stage 2 be important. Awaiting results.
icon url

williamssc

12/11/17 12:26 PM

#207365 RE: KMBJN #207357

Thanks for digging into results KMBJN. I'm not surprised to see that the placebo group accounts for the majority of dropouts. Placebo arm folks getting worse can't even swish and spit so giving up is very understandable.
icon url

WILD_4_IPIX

12/11/17 12:26 PM

#207366 RE: KMBJN #207357



icon url

slcimmuno

12/11/17 1:07 PM

#207376 RE: KMBJN #207357

thx - exactly: B-OM makings of a Winner

The "market" and traders may be yawning, but as others have noted, any improvement / prevention of severe OM is very meaningful for patients going through this very difficult and painful treatment and disease.

If it helps patients, it will be a winner in the marketplace of effective and safe medical treatments.